In a study published in this week’s PLoS Medicine, researchers have found that more than one species of bacteria may be causing the infectious eye disease trachoma. Six million people – most of whom live in crowded and unhygienic conditions in the developing world – are blind because of the disease and many more are actively infected. The possibility that multiple strains of the Chlamydiceae family of bacteria are involved in trachoma would involve a re-evaluation of vaccines and treatment programmes.
It is accepted that Chlamydia trachomatis (C. trachomatis) causes trachoma. The bacteria, some strains of which are associated with sexually transmitted infections, can also pass between people on hands and clothing; successive infections cause scarring of the inside of the eyelid. As the eyelashes of the infected eyes turn inward they scar the cornea - the transparent tissue covering the front of the eye - leading eventually to blindness. To investigate whether other species of Chlamydiceae also cause human trachoma, Deborah Dean and colleagues from Children’s Hospital Oakland Research Institute and the University of California San Francisco conducted their research in the Lumbini Zone of south-western Nepal where the disease is endemic. Obtaining specimens from 146 individuals in 9 households, they found that a third of the people who had trachoma were infected with only C. trachomatis, including not only the type that is typically described in trachoma-infected eyes but also the type usually associated with sexually transmitted diseases. Also, participants with Chlamidiacae infections of the eye were infected only with species previously associated with lung infections: one in five showed Chlamydophilia psittaci (C. psittaci) and one in ten Chlamydophila pneumoniae (C. pneumoniae); infection with these strains was just as strongly linked with severe inflammation of the eyes as was infection with the C. trachomatis bacteria already known to cause trachoma. Additionally, one third of the individuals had a mixed infection with two or three species.
Interventions to prevent trachoma by improving personal hygiene – such as the SAFE initiative promoted by the World Health Organization – have had limited success, and an effective vaccine may also be needed to eliminate the disease. The findings and their distribution by household and age provide evidence that C. psittaci and C. pneumoniae, in addition to C. trachomatis, are involved with trachoma and that these infections are widespread rather than sporadic. The findings would also explain why some people with active trachoma do not have C. trachomatis in their eyes, and suggest that antibiotics used for trachoma may need to be changed or used for longer periods of time to be effective against all three species. If these findings are confirmed in other trachoma-endemic regions, then future vaccines and treatments w ill need to combat all these bacteria and not just C. trachomatis.
Source: Public Library of Science
Related stories:
Sight saving stick
Scientists have developed the first inexpensive, sensitive and easy-to-use rapid test for trachoma, an eye infection that has led to more than one million women and children going blind.
Newly identified strains of Chlamydia trachomatis could produce new diseases
A new study led by a scientist at Children's Hospital Oakland Research Institute (CHORI) is the first to conclude that Chlamydia trachomatis is evolving at a rate faster than scientists first thought or imagined.
Neglected tropical diseases burden those overseas, but travelers also at risk
Though little known to most Americans, lymphatic filariasis, trachoma, leishmaniasis, onchocerciasis, schistosomiasis and other so-called neglected tropical diseases are responsible for severe health burdens, especially among the world’s poorest people. Together, it is estimated that these illnesses, most of which are caused by worms or other parasites, rank sixth among all conditions worldwide in robbing people of quality of life and life itself through disability or premature death, respectively.
New rapid Chlamydia test could enable 'test and treat' strategy
Wellcome Trust-funded researchers have successfully completed the clinical trial for a new rapid test for the sexually transmitted infection Chlamydia. The researchers believe the test, which is able to detect Chlamydia in less than 30 minutes – and often much faster – could be a valuable addition to screening programmes already in place, as well as providing a crucial diagnostic test in the developing world.
Study finds multiple neglected tropical diseases effectively treated with drugs
The neglected tropical diseases are a group of 13 infectious diseases, including elephantiasis, hookworm, African sleeping sickness and trachoma, which affect more than 1 billion people worldwide, most of whom live in extreme poverty. In a study published in the most recent
Journal of the American Medical Association, Madhuri Reddy, M.D., M.Sc., a geriatrician at Hebrew SeniorLife in Boston, says that treating two or more of them simultaneously for only pennies per dose can facilitate treatment of these diseases.
New drug resistance found in river blindness
A 20-year effort to control the spread of onchocerciasis, or river blindness, in African communities is threatened by the development of drug resistance in the parasite that causes the disease, a study by McGill University researchers has found.